Cargando…

Systematic Review of Safety and Efficacy of Second- and Third-Generation CD20-Targeting Biologics in Treating Immune-Mediated Disorders

BACKGROUND: B cells can contribute to immune-mediated disorders. Targeting CD20 has proved to be efficacious in several B cell-mediated immunopathologies, as illustrated by the use of rituximab, the first anti-CD20 monoclonal antibody (mAb). Following rituximab, second- and third-generation anti-CD2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaegi, Celine, Wuest, Benjamin, Crowley, Catherine, Boyman, Onur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847774/ https://www.ncbi.nlm.nih.gov/pubmed/35185862 http://dx.doi.org/10.3389/fimmu.2021.788830

Ejemplares similares

Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders
por: Kaegi, Celine, et al.
Publicado: (2020)

Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders
por: Kaegi, Celine, et al.
Publicado: (2019)

Systematic Review of Safety and Efficacy of IL-1-Targeted Biologics in Treating Immune-Mediated Disorders
por: Arnold, Dennis D., et al.
Publicado: (2022)

Editorial: Role of Neutrophils in Inflammatory Diseases
por: Marichal, Thomas, et al.
Publicado: (2020)

TLR9 Ligand Induces the Generation of CD20+ Plasmablasts and Plasma Cells from CD27+ Memory B-Cells
por: Geffroy-Luseau, Alexandrine, et al.
Publicado: (2011)

The Regulatory Effects of Interleukin-4 Receptor Signaling on Neutrophils in Type 2 Immune Responses
por: Egholm, Cecilie, et al.
Publicado: (2019)

Treg-selective IL-2 starvation synergizes with CD40 activation to sustain durable responses in lymphoma models
por: Stirm, Kristin, et al.
Publicado: (2023)

Seminar on Second and Third Generation SPC PABXs
por: Collective
Publicado: (1983)

Humoral and cellular immune response and the safety of third SARS-CoV-2 mRNA vaccine with longer interval after the second vaccination in kidney transplant recipients
por: Takai, Satoshi, et al.
Publicado: (2022)

Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic
por: de Sèze, Jérôme, et al.
Publicado: (2023)

CD20(+)CD22(+)ADAM28(+) B Cells in Tertiary Lymphoid Structures Promote Immunotherapy Response
por: Wu, Zhenghao, et al.
Publicado: (2022)

Wireless video communications: second to third generation systems and beyond
por: Hanzo, Lajos, et al.
Publicado: (2001)

Benchmarking second and third-generation sequencing platforms for microbial metagenomics
por: Meslier, Victoria, et al.
Publicado: (2022)

Treatment Effects of the Second-Generation Tyrosine Kinase Inhibitor Dasatinib on Autoimmune Arthritis
por: Guo, Kai, et al.
Publicado: (2019)

Combining CSPG4-CAR and CD20-CCR for treatment of metastatic melanoma
por: Teppert, Karin, et al.
Publicado: (2023)

Basics of Radiation Biology When Treating Hyperproliferative Benign Diseases
por: Rödel, Franz, et al.
Publicado: (2017)

CD49b/CD69-Dependent Generation of Resting T Helper Cell Memory
por: Hanazawa, Asami, et al.
Publicado: (2013)

Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages
por: Zeller, Tobias, et al.
Publicado: (2022)

Case Report: CD19 and CD20 monoclonal antibodies with sequential chemotherapy for refractory acute B-lymphocytic leukemia in children
por: Li, Jia-Nan, et al.
Publicado: (2023)

Characterization of Tissue-Engineered Posterior Corneas Using Second- and Third-Harmonic Generation Microscopy
por: Jay, Louis, et al.
Publicado: (2015)

New and Old Anti-CD20 Monoclonal Antibodies for Nephrotic Syndrome. Where We Are?
por: Basu, Biswanath, et al.
Publicado: (2022)

Influence of second-generation and third-generation mobile phones on critical care medical equipment
por: Van Lieshout, E, et al.
Publicado: (2006)

Third-Generation Capsule Endoscopy Outperforms Second-Generation Based on the Detectability of Esophageal Varices
por: Kunihara, Sayoko, et al.
Publicado: (2016)

Immunogenicity and safety of the booster BNT162b2 vaccine in patients with axial spondyloarthritis treated with biological disease-modifying drugs
por: Smetanova, Jitka, et al.
Publicado: (2022)

Anti-drug Antibodies Against a Novel Humanized Anti-CD20 Antibody Impair Its Therapeutic Effect on Primary Biliary Cholangitis in Human CD20- and FcγR-Expressing Mice
por: Moritoki, Yuki, et al.
Publicado: (2018)

The Role of Invariant Natural Killer T Cells in Dendritic Cell Licensing, Cross-Priming, and Memory CD8(+) T Cell Generation
por: Gottschalk, Catherine, et al.
Publicado: (2015)

Mobile radio communications: second and third generation cellular and WATM systems
por: Steele, Raymond, et al.
Publicado: (1999)

Comparing the effects of the second-and third-generation oral contraceptives on sexual functioning
por: Shahnazi, Mahnaz, et al.
Publicado: (2015)

Comparative transcriptome analysis of second- and third-generation merozoites of Eimeria necatrix
por: Su, Shijie, et al.
Publicado: (2017)

Study on the clinical features and prognosis of second and third generations of COVID-19
por: Deng, Chao, et al.
Publicado: (2022)

Comparison of efficacy and safety of second‐ and third‐generation TKIs for non‐small‐cell lung cancer with uncommon EGFR mutations
por: Hao, Yue, et al.
Publicado: (2023)

Generation and Function of Non-cell-bound CD73 in Inflammation
por: Schneider, Enja, et al.
Publicado: (2019)

Next Generation CD40 Agonistic Antibodies for Cancer Immunotherapy
por: Salomon, Ran, et al.
Publicado: (2022)

NFAT2 Regulates Generation of Innate-Like CD8(+) T Lymphocytes and CD8(+) T Lymphocytes Responses
por: Pachulec, Emilia, et al.
Publicado: (2016)

The Murine CD137/CD137 Ligand Signalosome: A Signal Platform Generating Signal Complexity
por: Choi, Beom K., et al.
Publicado: (2020)

Editorial: Generating and Sustaining Stable Autoantigen-Specific CD4 and CD8 Regulatory T Cells in Lupus
por: Datta, Syamal K., et al.
Publicado: (2022)

Distribution and efficacy of ofatumumab and ocrelizumab in humanized CD20 mice following subcutaneous or intravenous administration
por: Torres, Julia Baguña, et al.
Publicado: (2022)

A major histocompatibility complex class I–dependent subset of memory phenotype CD8(+) cells
por: Boyman, Onur, et al.
Publicado: (2006)

Dominant Role of CD80–CD86 Over CD40 and ICOSL in the Massive Polyclonal B Cell Activation Mediated by LAT(Y136F) CD4(+) T Cells
por: Chevrier, Stéphane, et al.
Publicado: (2012)

Cellular and humoral responses after second and third SARS-CoV-2 vaccinations in patients with autoimmune diseases treated with rituximab: specific T cell immunity remains longer and plays a protective role against SARS-CoV-2 reinfections
por: Egri, Natalia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gfc2bklai51f4857eh94t6od2i